Abstract
BackgroundRectovaginal fistulas represent 5% of all anorectal fistulae and are a disastrous manifestation of Crohn’s disease that negatively affects patients’ social and sexual quality of life. Treatment remains challenging for colorectal surgeons, and the recurrence rate remains high despite the numerous available options.Case presentationWe describe a 31-year-old female patient with a Crohn’s disease-related recurrent perineo-vaginal and recto-vaginal fistulae and a concomitant mullerian anomaly. She complained of severe dyspareunia associated with penetration difficulties. The patient’s medical history was also significant for a previous abdominal laparoscopic surgery for endometriosis for the removal of macroscopic nodules and a septate uterus with cervical duplication and a longitudinal vaginal septum. The patient was successfully treated using a Martius’ flap. The postoperative outcome was uneventful, and no recurrence of the fistula occurred at the last follow-up, eight months from the closure of the ileostomy.ConclusionMartius’ flap was first described in 1928, and it is considered a good option in cases of rectovaginal fistulas in patients with Crohn’s disease.The patient should be referred to a colorectal centre with expertise in this disease to increase the surgical success rate.
Highlights
Rectovaginal fistulas represent 5% of all anorectal fistulae and are a disastrous manifestation of Crohn’s disease that negatively affects patients’ social and sexual quality of life
We describe the preoperative and operative details of Martius’ flap in the management of a 31-year-old female with Crohn’s disease (CD)-related recurrent perineovaginal and rectovaginal fistula (RVF) with a concomitant mullerian anomaly
RVFs related to CD are challenging for surgeons, and a very high propensity to recur is observed, with published rates ranging from 25% to 80% [7, 21, 22]
Summary
Martius’ flap was first described in 1928, and it is considered a good option in cases of rectovaginal fistulas in patients with Crohn’s disease.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have